Remedium Lifecare Complete Financial Statements
REMLIFE • Review detailed financials to uncover trends, confirm thesis & journal trades
1 Years of Data
2025 - 2025
Complete Financial Data Export
Export complete financial statements for Remedium Lifecare (REMLIFE).
Downloads include all available records across all periods.
For market performance, see the
REMLIFE stock price today
.
Profitability Ratios
Net Profit Margin
7.89%
2025 data
EBITDA Margin
9.65%
2025 data
Operating Margin
7.00%
2025 data
Return on Assets
0.52%
2025 data
Return on Equity
20.45%
2025 data
Balance Sheet Ratios
Debt to Equity
39.09
2025 data
Equity Ratio
2.56%
2025 data
Asset Turnover
0.07
2025 data
Year-over-Year Growth Analysis
Comparing Mar 2025 vs Sept 2025
Revenue Growth
-57.0%
Year-over-Year
Net Profit Growth
+550.0%
Year-over-Year
Expense Growth
-60.8%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 |
|---|---|---|---|
| Revenue | 114 | 265 | 117 |
| Expenses | 104 | 265 | 112 |
| EBITDA | 11 | 0 | 5 |
| Operating Profit Margin % | 7.00% | 0.00% | 2.00% |
| Depreciation | 0 | 0 | 0 |
| Interest | 0 | 2 | 0 |
| Profit Before Tax | 10 | -1 | 6 |
| Tax | 2 | 1 | 1 |
| Net Profit | 9 | -2 | 5 |
| Earnings Per Share (₹) | 0.10 | -0.05 | 0.05 |
Related Pages for Remedium Lifecare
Additional stock information and data for REMLIFE
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 |
|---|---|
| ASSETS | |
| Total Assets | 1,720 |
| Current Assets | 1,720 |
| Fixed Assets | 0 |
| Capital Work in Progress | 0 |
| Investments | 0 |
| Other Assets | 1,720 |
| LIABILITIES | |
| Total Liabilities | 1,720 |
| Current Liabilities | 0 |
| Non-Current Liabilities | |
| SHAREHOLDERS' EQUITY | |
| Total Equity | 44 |
| Share Capital | 40 |
| Reserves & Surplus | 4 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 |
|---|---|
| Operating Activities | -1,135 |
| Investing Activities | 0 |
| Financing Activities | 1,136 |
| Net Cash Flow | 1 |